Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Qiagen N.V. Common Shares
(NY:
QGEN
)
50.22
+0.05 (+0.09%)
Delayed Quote
Updated: 9:39 AM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qiagen N.V. Common Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
January 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
January 18, 2022
From
QIAGEN N.V.
Via
Business Wire
What Does Qiagen's Debt Look Like?
↗
January 13, 2022
Over the past three months, shares of Qiagen (NYSE:QGEN) moved lower by 5.06%. Before we understand the importance of debt, let us look at how much debt Qiagen has. Qiagen...
Via
Benzinga
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
January 10, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
January 07, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
January 06, 2022
From
QIAGEN N.V.
Via
Business Wire
Free COVID Tests: What Stocks Will Benefit?
↗
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
↗
December 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...
Via
Benzinga
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
December 09, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
December 02, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
November 29, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen Says Its COVID-19 PCR Tests Can Detect The New South African Variant
↗
November 26, 2021
Qiagen N.V. (NYSE:QGEN) announced that its polymerase c...
Via
Benzinga
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...
Via
FinancialNewsMedia
QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050
November 08, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen, Becton Dickinson Settle Patent Infringement Lawsuit For $53M
↗
November 08, 2021
Qiagen N.V. (NYSE: QGEN) settled with Becton Dickinson & Co (NYSE: BDX) a patent infringement lawsuit related to Qiagen's NeuMoDx 96 and NeuMoDx...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
QIAGEN and BD Settle Patent Infringement Lawsuit
November 05, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen NV (QGEN) Q3 2021 Earnings Call Transcript
↗
November 04, 2021
QGEN earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Qiagen Clocks 17% Increase In Non-COVID Product Sales; Raises FY21 Guidance
↗
November 04, 2021
Qiagen N.V.'s (NYSE: QGEN) Q3 revenues grew 11% Y/Y to $535 million (+10% at constant exchange rates), well above the consensus of $434.97 million. Non-COVID...
Via
Benzinga
QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021
November 03, 2021
From
QIAGEN N.V.
Via
Business Wire
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
↗
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
November 02, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Strengthens UK Footprint With Move to New Manchester Facilities
October 22, 2021
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For November 3, 2021
↗
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
QIAGEN N.V. to Release Results for Q3 2021 and First Nine Months of 2021
October 20, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions
October 19, 2021
From
QIAGEN N.V.
Via
Business Wire
Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx
↗
October 01, 2021
Qiagen NV (NYSE: QGEN) won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288 integrated PCR testing...
Via
Benzinga
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
September 30, 2021
From
QIAGEN N.V.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
↗
October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:
Via
Benzinga
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
September 28, 2021
Via
FinancialNewsMedia
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
